517 related articles for article (PubMed ID: 28259425)
21. Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry.
Gonçalves MJ; Sousa S; Inês LS; Duarte C; Borges J; Silva C; Romão VC; Terroso G; Bernardes M; Cerqueira M; Raposo A; Sequeira G; Barcelos A; Macieira C; Canas da Silva J; Costa L; Pereira da Silva JA; Cunha-Miranda L; Da Silva JA; Canhão H; Santos MJ
Lupus; 2015 Mar; 24(3):256-62. PubMed ID: 25318970
[TBL] [Abstract][Full Text] [Related]
22. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
[TBL] [Abstract][Full Text] [Related]
23. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology.
Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo-Izquierdo M; Loza E; García de Yebenes MJ; Pego-Reigosa JM; ;
Reumatol Clin; 2014; 10(1):17-24. PubMed ID: 23871155
[TBL] [Abstract][Full Text] [Related]
24. Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
González-Naranjo LA; Betancur OM; Alarcón GS; Ugarte-Gil MF; Jaramillo-Arroyave D; Wojdyla D; Pons-Estel GJ; Rondón-Herrera F; Vásquez-Duque GM; Quintana-López G; Da Silva NA; Tavares Brenol JC; Reyes-Llerena G; Pascual-Ramos V; Amigo MC; Massardo L; Alfaro-Lozano J; Segami MI; Esteva-Spinetti MH; Iglesias-Gamarra A; Pons-Estel BA
Semin Arthritis Rheum; 2016 Jun; 45(6):675-83. PubMed ID: 26698222
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.
Molad Y; Gorshtein A; Wysenbeek AJ; Guedj D; Majadla R; Weinberger A; Amit-Vazina M
Lupus; 2002; 11(6):356-61. PubMed ID: 12139373
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.
Ugarte-Gil MF; Wojdyla D; Pastor-Asurza CA; Gamboa-Cárdenas RV; Acevedo-Vásquez EM; Catoggio LJ; García MA; Bonfá E; Sato EI; Massardo L; Pascual-Ramos V; Barile LA; Reyes-Llerena G; Iglesias-Gamarra A; Molina-Restrepo JF; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
Lupus; 2018 Apr; 27(4):536-544. PubMed ID: 28857715
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state.
Romo-Tena J; la Garza RR; Bartnicki-Navarrete I; Alcocer-Varela J; Gómez-Martin D
Clin Rheumatol; 2018 Nov; 37(11):3033-3042. PubMed ID: 30056524
[TBL] [Abstract][Full Text] [Related]
28. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
[TBL] [Abstract][Full Text] [Related]
29. Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.
García MA; Alarcón GS; Boggio G; Hachuel L; Marcos AI; Marcos JC; Gentiletti S; Caeiro F; Sato EI; Borba EF; Brenol JC; Massardo L; Molina-Restrepo JF; Vásquez G; Guibert-Toledano M; Barile-Fabris L; Amigo MC; Huerta-Yáñez GF; Cucho-Venegas JM; Chacón-Diaz R; Pons-Estel BA;
Rheumatology (Oxford); 2014 Aug; 53(8):1431-8. PubMed ID: 24633413
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
[TBL] [Abstract][Full Text] [Related]
32. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
[TBL] [Abstract][Full Text] [Related]
34. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort.
Lopez R; Davidson JE; Beeby MD; Egger PJ; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):491-8. PubMed ID: 22109798
[TBL] [Abstract][Full Text] [Related]
35. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.
Elera-Fitzcarrald C; Alva M; Gamboa-Cardenas R; Mora-Trujillo CS; Zevallos F; García-Poma A; Medina M; Rodriguez-Bellido Z; Perich-Campos RA; Pastor-Asurza CA; Segami MI; Ugarte-Gil MF
Lupus; 2018 May; 27(6):913-919. PubMed ID: 29301472
[TBL] [Abstract][Full Text] [Related]
37. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
38. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
Fasano S; Margiotta DPE; Pierro L; Navarini L; Riccardi A; Afeltra A; Valentini G
Clin Rheumatol; 2019 Feb; 38(2):457-463. PubMed ID: 30194649
[TBL] [Abstract][Full Text] [Related]
39. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.
Luijten RK; Cuppen BV; Bijlsma JW; Derksen RH
Lupus; 2014 Dec; 23(14):1512-6. PubMed ID: 25078055
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
